FFA
PTCT icon

Founders Financial Alliance’s PTC Therapeutics PTCT Stock Holding History

Founders Financial Alliance’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-600
Closed -$28K – 1041
2020
Q3 		$28K Buy
+600
New +$29.5K 0.02% 494

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Founders Financial Alliance's PTCT Position: Q4 2020 in Review

Founders Financial Alliance sold out of PTC Therapeutics (PTCT) in Q4 2020, closing a stake of 600 shares — an estimated $28K sold.

Founders Financial Alliance first reported a position in PTCT in Q3 2020 and held it in 1 quarter. The position peaked at $28K in Q3 2020. 214 funds tracked by Wall St. Rank hold PTCT as of Q4 2020.

  • Founders Financial Alliance reported no remaining PTC Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Founders Financial Alliance sold 600 PTC Therapeutics shares in Q4 2020, an estimated $28K.
  • Founders Financial Alliance first reported a position in PTC Therapeutics in Q3 2020 and held it in 1 quarter.
  • Founders Financial Alliance's PTC Therapeutics position peaked at $28K in Q3 2020.
  • 214 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.